Skip to main content

deupirfenidone

deupirfenidone: 3 clinical trials tracked.

deupirfenidone evidence translation

What we can confirm

3 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about deupirfenidone, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 1 study sponsors
Clinical Trials (3)

A Randomized, Double-Blind, Head-to-Head Phase 3 Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone at 52 Weeks in Adults With Idiopathic Pulmonary Fibrosis (SURPASS-IPF)

NCT07284602·Phase 3·PRTC
Recruiting

Primary endpoint: Absolute change in forced vital capacity (FVC) measured in mL

InterventionalRandomizedquadruple1,100 targetStarted 2026-06Completion 2029-079 sites · United StatesPureTech

A Randomized Double-blind, Four-Arm Active and Placebo-controlled Dose-Finding Trial to Evaluate the Efficacy, Tolerability, Safety and Dose Response of LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

NCT05321420·Phase 2·PRTC
Active, not recruiting

Primary endpoint: Rate of decline in Forced Vital Capacity over 26 weeks (Part A)

InterventionalRandomizedquadruple240 targetStarted 2022-07Completion 2025-1250 sites · Argentina, Chile, Colombia, Georgia…PureTech

A Phase 1, Double-Blind, Randomized, Crossover Study in Older Healthy Subjects to Compare the Safety, Tolerability, and Pharmacokinetics of Lyt-100 (Deupirfenidone) to Pirfenidone

NCT07456800·Phase 1·PRTC
Completed

Primary endpoint: Part 1: Cmax of BID deupirfenidone versus TID pirfenidone

InterventionalRandomizedquadruple116 enrolledStarted 2021-07Completion 2022-013 sites · United StatesPureTech